Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Resino

Showing results (321-330 of 418) with videos related to

Pageof 42
Sort By:
Journal of Translational Medicine|December 8, 2018
Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapyLuz M Medrano, Mónica Gutiérrez-Rivas, Julià Blanco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2013
Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markersAmanda Fernández-Rodríguez, Juan Berenguer, María A Jiménez-Sousa, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapyMaría Guzmán-Fulgencio, Juan Berenguer, Dariela Micheloud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2010
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIVJose Medrano, Karin Neukam, Norma Rallón, et al.
Journal of Clinical Medicine|October 27, 2019
Nosocomial Vs. Community-Acquired Infective Endocarditis in Spain: Location, Trends, Clinical Presentation, Etiology, and Survival in the 21st CenturyChristian Ortega-Loubon, María Fe Muñoz-Moreno, Irene Andrés-García, et al.
AIDS (London, England)|April 13, 2004
Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected childrenIsabel Galán, José L Jiménez, Milagros González-Rivera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
Sex and age-related differences in humoral and cellular responses to the recombinant zoster vaccine in people living with HIVCristina Díez, Carlos Pita-Martínez, Marta Quero-Delgado, et al.
AIDS (London, England)|February 7, 2014
SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patientsDaniel Pineda-Tenor, Dariela Micheloud, Juan Berenguer, et al.
Clinical and Translational Medicine|July 30, 2017
CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional studyMaría Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, et al.
Journal of Viral Hepatitis|August 8, 2017
Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patientsN Merchante, T Aldámiz-Echevarría, M García-Álvarez, et al.
Pageof 42

Showing results (321-330 of 418) with videos related to

Sort By:
Pageof 42
Journal of Translational Medicine|December 8, 2018
Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapyLuz M Medrano, Mónica Gutiérrez-Rivas, Julià Blanco, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2013
Prediction of hepatic fibrosis in patients coinfected with HIV and hepatitis C virus based on genetic markersAmanda Fernández-Rodríguez, Juan Berenguer, María A Jiménez-Sousa, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
European mitochondrial haplogroups are associated with CD4+ T cell recovery in HIV-infected patients on combination antiretroviral therapyMaría Guzmán-Fulgencio, Juan Berenguer, Dariela Micheloud, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2010
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIVJose Medrano, Karin Neukam, Norma Rallón, et al.
Journal of Clinical Medicine|October 27, 2019
Nosocomial Vs. Community-Acquired Infective Endocarditis in Spain: Location, Trends, Clinical Presentation, Etiology, and Survival in the 21st CenturyChristian Ortega-Loubon, María Fe Muñoz-Moreno, Irene Andrés-García, et al.
AIDS (London, England)|April 13, 2004
Virological phenotype switches under salvage therapy with lopinavir-ritonavir in heavily pretreated HIV-1 vertically infected childrenIsabel Galán, José L Jiménez, Milagros González-Rivera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2025
Sex and age-related differences in humoral and cellular responses to the recombinant zoster vaccine in people living with HIVCristina Díez, Carlos Pita-Martínez, Marta Quero-Delgado, et al.
AIDS (London, England)|February 7, 2014
SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patientsDaniel Pineda-Tenor, Dariela Micheloud, Juan Berenguer, et al.
Clinical and Translational Medicine|July 30, 2017
CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional studyMaría Ángeles Jiménez-Sousa, Ana Zaida Gómez-Moreno, Daniel Pineda-Tenor, et al.
Journal of Viral Hepatitis|August 8, 2017
Bacterial translocation and clinical progression of HCV-related cirrhosis in HIV-infected patientsN Merchante, T Aldámiz-Echevarría, M García-Álvarez, et al.
Pageof 42